JOHNSON INVESTMENT COUNSEL INC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
JOHNSON INVESTMENT COUNSEL INC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$180,000
-24.1%
62,4600.0%0.00%
-33.3%
Q2 2021$237,000
+12.3%
62,4600.0%0.00%0.0%
Q1 2021$211,000
+20.6%
62,4600.0%0.00%0.0%
Q4 2020$175,000
+11.5%
62,4600.0%0.00%0.0%
Q3 2020$157,000
-81.3%
62,460
+0.8%
0.00%
-82.4%
Q2 2020$841,000
+74.8%
61,960
-18.6%
0.02%
+88.9%
Q4 2019$481,000
+61.4%
76,1410.0%0.01%
+50.0%
Q3 2019$298,000
-19.0%
76,1410.0%0.01%
-25.0%
Q2 2019$368,000
-40.9%
76,1410.0%0.01%
-38.5%
Q1 2019$623,000
+83.8%
76,141
+23.9%
0.01%
+62.5%
Q4 2018$339,000
-37.5%
61,4620.0%0.01%
-33.3%
Q3 2018$542,000
-11.6%
61,4620.0%0.01%
-20.0%
Q2 2018$613,000
+4.6%
61,462
-0.2%
0.02%0.0%
Q1 2018$586,000
-35.8%
61,567
+0.2%
0.02%
-34.8%
Q4 2017$913,000
-25.7%
61,462
-1.6%
0.02%
-28.1%
Q3 2017$1,228,000
+35.1%
62,462
-1.4%
0.03%
+28.0%
Q2 2017$909,000
+51.2%
63,321
-3.2%
0.02%
+47.1%
Q1 2017$601,000
-7.5%
65,392
+4.7%
0.02%
-15.0%
Q4 2016$650,000
-27.9%
62,462
-37.4%
0.02%
-31.0%
Q3 2016$902,000
+24.6%
99,765
+3.0%
0.03%
+20.8%
Q2 2016$724,000
-14.4%
96,835
+3.1%
0.02%
-20.0%
Q1 2016$846,000
-28.0%
93,905
+3.2%
0.03%
-26.8%
Q4 2015$1,175,000
+24.2%
90,975
-7.2%
0.04%
+17.1%
Q3 2015$946,000
+22.1%
98,001
+30.0%
0.04%
+34.6%
Q2 2015$775,00075,3880.03%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders